Quitting Smoking During Addiction Recovery Was Linked to Better Recovery, Not More Relapse
Evidence review & editorial synthesis
For decades, addiction treatment has carried an intuitive fear: asking someone to give up cigarettes while they are also trying to stop alcohol or drugs might be one change too many.
The evidence increasingly says otherwise.
In a nationally representative US study of 2,652 adults with a history of substance use disorder, periods in which people transitioned from current smoking to former smoking were associated with 30% higher adjusted odds of sustained recovery from their other substance disorder. Earlier randomized-trial reviews have reached an equally important conclusion: treating tobacco dependence does not appear to make alcohol or drug outcomes worse.
That matters because cigarettes are not a harmless consolation prize. Persistent smoking can cost more than a decade of life.
The feared relapse signal did not appear
The underlying 2025 JAMA Psychiatry study used longitudinal data from the Population Assessment of Tobacco and Health study.
Rather than simply comparing smokers with nonsmokers, researchers examined changes within the same people over time. Participants had a history of substantial substance-use symptoms, and recovery was defined as having no symptoms during the previous year after previously reporting a high lifetime symptom burden.
When someone moved from current smoking to former smoking, the adjusted odds of being in SUD recovery were 30% higher than during periods of continued smoking.
The result remained positive when smoking status was shifted one year earlier, reducing the possibility that people simply quit cigarettes after their other addiction had already improved. A second national cohort produced a similar association.
This does not prove that quitting cigarettes caused recovery. People who successfully stop smoking may also be making other changes that improve their chances of remaining abstinent.
But it strongly challenges the idea that smoking cessation itself destabilizes recovery.
Cigarettes and other addictions are unusually intertwined
Smoking is substantially more common among people with alcohol and other substance use disorders than in the general population.
That overlap probably reflects several processes at once. Nicotine and other addictive drugs engage overlapping reward and reinforcement systems. Smoking can become tightly conditioned to drinking, social settings, stress, particular people and even the physical rituals surrounding another drug. Shared genetic, psychiatric and environmental vulnerabilities can increase the likelihood of multiple addictions as well.
This means the cigarette may not always be an isolated habit sitting safely outside the recovery process. It can remain part of the old network of cues and rewards.
Historically, some treatment programs nevertheless tolerated smoking because nicotine seemed like the lesser problem and because clinicians feared that simultaneous cessation might overload patients.
Randomized evidence has not supported that fear.
A Cochrane review of smoking-cessation interventions in people undergoing treatment or recovery for alcohol and other drug dependence found that tobacco treatment increased smoking abstinence without reducing abstinence from alcohol or other drugs. An earlier meta-analysis of 19 randomized trials even found a higher likelihood of long-term alcohol and illicit-drug abstinence among people offered smoking-cessation treatment, although later reviews have been more conservative about whether tobacco treatment actively improves other substance outcomes.
The consistent part of the story is simpler: there is no convincing evidence that helping someone quit cigarettes sabotages recovery.
Leaving cigarettes alone carries an enormous cost
That would already be enough to challenge the old treatment philosophy. The mortality numbers make the argument much stronger.
A major prospective US study involving more than 200,000 adults found that current smokers had approximately three times the all-cause death rate of people who had never smoked. Persistent smokers lost more than 10 years of life expectancy on average.
Quitting recovered a remarkable amount of that lost time.
People who stopped between ages 25 and 34 gained about 10 years of life compared with those who continued smoking. Quitting between 35 and 44 recovered about nine years, and quitting between 45 and 54 recovered about six.
Stopping before age 40 eliminated roughly 90% of the excess mortality associated with continued smoking.
For someone who has already fought through alcohol, opioid, stimulant or another drug addiction, leaving tobacco dependence untreated can therefore preserve one of the largest remaining preventable threats to long-term health.
Quitting does not appear to make mental health worse either
Another persistent belief is that cigarettes are necessary for coping with stress, anxiety or low mood.
Nicotine can certainly produce short-term changes in attention and mood. But regular smoking also creates repeated cycles of nicotine withdrawal and relief. A cigarette can therefore feel calming partly because it temporarily removes discomfort generated by dependence itself.
Longer-term research points in a different direction.
A systematic review and meta-analysis comparing people who quit with those who continued smoking found reductions in anxiety, depression and stress after cessation, alongside improvements in positive mood and psychological quality of life. The pattern did not appear to be confined to psychologically healthy populations.
That does not mean the first days of quitting are pleasant. Withdrawal can temporarily cause irritability, restlessness, poor concentration, sleep disturbance and craving.
The important distinction is between short-term withdrawal and longer-term mental health.
The best way to quit is no longer just willpower
Modern smoking cessation has several treatments with strong evidence behind them.
A large Cochrane network meta-analysis covering 319 studies and more than 157,000 adults found the highest quit rates with nicotine e-cigarettes, varenicline and cytisine, with combination nicotine replacement therapy also among the strongest options.
Varenicline acts on the same nicotinic receptor system targeted by nicotine. It reduces craving and withdrawal while also reducing the rewarding effect of smoking.
Cytisine uses a related mechanism and has been used in parts of Europe for decades, although access differs substantially between countries.
Combination nicotine replacement generally means a steady background treatment such as a nicotine patch plus a faster-acting product such as gum or lozenges for breakthrough cravings. Using two forms together works better than relying on a single nicotine-replacement product alone.
Nicotine e-cigarettes have also accumulated substantial randomized evidence as a cessation tool. For an existing smoker, completely replacing combustible cigarettes with a regulated nicotine vaping product can increase the probability of quitting. That does not make vaping harmless, and continuing both cigarettes and vaping is not equivalent to stopping smoking.
The broader lesson is important: dependence is treatable. Someone does not have to defeat nicotine through willpower alone.
Recovery may work better as one process
The new evidence reframes a familiar addiction-treatment question.
Instead of asking whether someone in recovery can handle giving up cigarettes too, the better question may be why one powerful addiction should automatically be left untreated.
Smoking shares cues, reinforcement and vulnerability with other addictions. It imposes one of the largest preventable mortality risks in medicine. Effective treatments exist. And the feared penalty of increased alcohol or drug relapse has repeatedly failed to appear.
The newest cohort cannot prove that quitting cigarettes makes sobriety stronger. But it adds to a growing body of evidence suggesting that nicotine treatment belongs inside addiction recovery rather than waiting outside it.
For many patients, the cigarette may not be protecting recovery at all. Removing it could be part of recovery itself.
Scientific References & Further Reading
- Evidence Commentary: “Smoking cessation during addiction recovery does not increase relapse risk.” (Frazer K. Evidence-Based Nursing. 2026. doi:10.1136/ebnurs-2025-104452. PMID:42791064.)
- Primary Recovery Study: “Cigarette Smoking During Recovery From Substance Use Disorders.” (Parks MJ, Blanco C, Creamer MR, et al. JAMA Psychiatry. 2025;82(10):1002-1008. doi:10.1001/jamapsychiatry.2025.1976.)
- Concurrent Cessation Review: “Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.” (Cochrane systematic review of tobacco cessation interventions in people receiving treatment for or recovering from substance dependence.)
- Smoking Mortality: “21st-Century Hazards of Smoking and Benefits of Cessation in the United States.” (Jha P, Ramasundarahettige C, Landsman V, et al. N Engl J Med. 2013;368:341-350. doi:10.1056/NEJMsa1211128.)
- Smoking Cessation Treatments: “Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.” (Lindson N, Theodoulou A, Ordóñez-Mena JM, et al. Cochrane Database Syst Rev. 2023;9:CD015226.)
- Mental Health After Quitting: “Change in mental health after smoking cessation: systematic review and meta-analysis.” (Taylor G, McNeill A, Girling A, et al. BMJ. 2014;348:g1151.)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not a substitute for diagnosis, treatment, or individualized medical care.

